Literature DB >> 30165040

Solution structure of SHIP2 SH2 domain and its interaction with a phosphotyrosine peptide from c-MET.

Zi Wang1, Yao Nie1, Kunxiao Zhang2, Henghao Xu2, Theresa A Ramelot3, Michael A Kennedy3, Maili Liu4, Jiang Zhu5, Yunhuang Yang6.   

Abstract

SH2 domain-containing inositol 5-phosphatase 2 (SHIP2) binds with the Y1356-phosphorylated hepatocyte growth factor (HGF) receptor, c-MET, through its SH2 domain, which is essential for the role of SHIP2 in HGF-induced cell scattering and cell spreading. Previously, the experimental structure of the SH2 domain from SHIP2 (SHIP2-SH2) had not been reported, and its interaction with the Y1356-phosphorylated c-MET had not been investigated from a structural point of view. In this study, the solution structure of SHIP2-SH2 was determined by NMR spectroscopy, where it was found to adopt a typical SH2-domain fold that contains a positively-charged pocket for binding to phosphotyrosine (pY). The interaction between SHIP2-SH2 and a pY-containing peptide from c-MET (Y1356 phosphorylated) was investigated through NMR titrations. The results showed that the binding affinity of SHIP2-SH2 with the phosphopeptide is at low micromolar level, and the binding interface consists of the positively-charged pocket and its surrounding regions. Furthermore, R28, S49 and R70 were identified as key residues for the binding and may directly interact with the pY. Taken together, these findings provide structural insights into the binding of SHIP2-SH2 with the Y1356-phosphorylated c-MET, and lay a foundation for further studies of the interactions between SHIP2-SH2 and its various binding partners.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HGFR; INPPL1; SH2 domain; Solution NMR structure; Tyrosine phosphorylation

Mesh:

Substances:

Year:  2018        PMID: 30165040      PMCID: PMC6251712          DOI: 10.1016/j.abb.2018.08.012

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  43 in total

1.  Dimer formation through domain swapping in the crystal structure of the Grb2-SH2-Ac-pYVNV complex.

Authors:  N Schiering; E Casale; P Caccia; P Giordano; C Battistini
Journal:  Biochemistry       Date:  2000-11-07       Impact factor: 3.162

Review 2.  The language of SH2 domain interactions defines phosphotyrosine-mediated signal transduction.

Authors:  Bernard A Liu; Brett W Engelmann; Piers D Nash
Journal:  FEBS Lett       Date:  2012-05-05       Impact factor: 4.124

Review 3.  Using chemical shift perturbation to characterise ligand binding.

Authors:  Mike P Williamson
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2013-03-21       Impact factor: 9.795

4.  Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity.

Authors:  Mark W Sleeman; Katherine E Wortley; Ka-Man V Lai; Lori C Gowen; Jennifer Kintner; William O Kline; Karen Garcia; Trevor N Stitt; George D Yancopoulos; Stanley J Wiegand; David J Glass
Journal:  Nat Med       Date:  2005-01-16       Impact factor: 53.440

5.  Src homology 2-containing inositol 5-phosphatase 1 binds to the multifunctional docking site of c-Met and potentiates hepatocyte growth factor-induced branching tubulogenesis.

Authors:  M Stefan; A Koch; A Mancini; A Mohr; K M Weidner; H Niemann; T Tamura
Journal:  J Biol Chem       Date:  2000-11-07       Impact factor: 5.157

6.  SHIP2 overexpression strongly reduces the proliferation rate of K562 erythroleukemia cell line.

Authors:  Sylvie Giuriato; Daniel Blero; Bernard Robaye; Catherine Bruyns; Bernard Payrastre; Christophe Erneux
Journal:  Biochem Biophys Res Commun       Date:  2002-08-09       Impact factor: 3.575

Review 7.  The role of the inositol polyphosphate 5-phosphatases in cellular function and human disease.

Authors:  Lisa M Ooms; Kristy A Horan; Parvin Rahman; Gillian Seaton; Rajendra Gurung; Dharini S Kethesparan; Christina A Mitchell
Journal:  Biochem J       Date:  2009-04-01       Impact factor: 3.857

8.  Stereospecific nuclear magnetic resonance assignments of the methyl groups of valine and leucine in the DNA-binding domain of the 434 repressor by biosynthetically directed fractional 13C labeling.

Authors:  D Neri; T Szyperski; G Otting; H Senn; K Wüthrich
Journal:  Biochemistry       Date:  1989-09-19       Impact factor: 3.162

9.  The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man.

Authors:  Evelyne Marion; Pamela Jane Kaisaki; Valérie Pouillon; Cyril Gueydan; Jonathan C Levy; André Bodson; Georges Krzentowski; Jean-Claude Daubresse; Jean Mockel; Jens Behrends; Geneviève Servais; Claude Szpirer; Véronique Kruys; Dominique Gauguier; Stéphane Schurmans
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

10.  Structural basis for phosphoinositide substrate recognition, catalysis, and membrane interactions in human inositol polyphosphate 5-phosphatases.

Authors:  Lionel Trésaugues; Camilla Silvander; Susanne Flodin; Martin Welin; Tomas Nyman; Susanne Gräslund; Martin Hammarström; Helena Berglund; Pär Nordlund
Journal:  Structure       Date:  2014-04-03       Impact factor: 5.006

View more
  2 in total

1.  ARQ-197 enhances the antitumor effect of sorafenib in hepatocellular carcinoma cells via decelerating its intracellular clearance.

Authors:  Xudong Gao; Hebing Chen; Xin Huang; Hao Li; Zhen Liu; Xiaochen Bo
Journal:  Onco Targets Ther       Date:  2019-02-26       Impact factor: 4.147

2.  Structural Insights into the Binding Propensity of Human SHIP2 SH2 to Oncogenic CagA Isoforms from Helicobacter pylori.

Authors:  Zi Wang; Yubao Shan; Ru Wang; Heng Zhou; Rui Hu; Ying Li; Jiang Zhu; Yunhuang Yang; Maili Liu
Journal:  Int J Mol Sci       Date:  2022-09-25       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.